HBCD draft Risk Profile: Request for comments

Endosulfan: Request draft RME comments & additional information

Letter date: 9 April 2010

Invitation to review and provide comments on the draft risk management evaluation on endosulfan and to submit additional information (adverse human health effects, costs and benefits of implementing control measures, and alternatives)